Sickle Cell Anemia
Sickle Cell Anemia
SICKLE CELL ANEMIA AND MALARIA
Sickle cell anemia is a severe and commonly fatal anemia, or failure of oxygen transfer. Its name derives from the fact that the red blood cells (RBCs), the transporters of oxygen, which are normally lozenge shaped, collapse into characteristic sickle-shaped cells under the influence of the disease. These red blood cells have drastically reduced ability to transport oxygen and a reduced life expectancy (10–12 days instead of the normal 120 days). The condition is often punctuated by painful “crises” resulting from the fact that the sickle shaped cells are elongated and relatively stiff and may periodically block capillaries because they clump, or agglutinate. The condition was first described in Western medicine by James Herrick in a series of publications between 1910 and 1912.
SYMPTOMS AND CAUSES
A wide range of symptoms may result, ranging from the weakness and lassitude characteristic of anemia to acute and/or chronic pain. Specific symptoms include shortness of breath, jaundice, poor physical development, small slender bodies, delayed sexual maturity, swelling of hands and feet, impaired mental function, and rheumatism. It may also cause local failure of blood supply, possibly resulting in blindness, strokes, and damage to the heart, brain, lungs, spleen, gastrointestinal tract, and kidneys. In addition, it can cause painful priapism, resulting in damage to the penis. One of its most dangerous consequences is reduced resistance to infection, particularly influenza, pneumonia, and meningitis. Fewer than 10 percent of individuals with sickle cell anemia survive to adulthood, and their evolutionary fitness or reproductive success (compared to average fitness, defined as 1.0) is about 0.1.
Sickle cell anemia was the first genetic disease whose molecular basis was identified. The condition is the result of having two copies (i.e., the homozygote condition) of the HbS allele (variant) of the gene for the production of hemoglobin, a complex molecule of four polypeptide (amino acid) chains. Hemoglobin is found in red blood cells and is the molecule that grabs oxygen from the lungs and transports oxygen in the blood for use in the body. The HbS allele results from a point mutation of the HbA allele, resulting in the substitution of amino acid valine for glutamic acid in position six on the beta chain of the hemoglobin molecule. The codon change is a substitution of GTG for GAG.
HbS is a classic autosomal recessive trait. The alleles are distributed in a normal Mendelian manner such that heterozygote parents (i.e., each with one copy of the allele) will produce homozygote “normals,” sickle cell carriers, and homozygotes with full-fledged sickle cell disease in a ratio of 1:2:1. On average, 25 percent of children born to two heterozygote parents will have the disease. Homozygous individuals are heavily afflicted, whereas heterozygotes possess both types of hemoglobin and function normally unless placed in conditions of high oxygen stress such as heavy labor, athletics, or high-altitude activity. It is now known that the disease is carried by about one in twelve African Americans, resulting in sickle cell anemia in one of 500 births to African Americans, although the rate is gradually declining.
The mutation(s) may have occurred separately several times: in as many as four locations in Africa and an additional one in India or Arabia. However, that interpretation remains controversial. The allele may also have radiated outward from a center in West Africa or, conversely, into Africa from the Middle East. The modern distribution of the allele results in significant part from patterns of trade and travel under Muslim and then Christian dominion of areas of the Middle East and Africa. In the early twenty-first century it occurs with the highest frequency in Central Africa, where 30 percent or more of the population can be carriers, as well as in northeast and northwest India, Turkey, and Saudi Arabia. It also reaches high frequencies in parts of Greece and is found elsewhere in Mediterranean Europe.
SICKLE CELL ANEMIA AND MALARIA
The persistence of such a deleterious allele posed an evolutionary paradox for biological scientists: Why doesn’t the allele simply disappear through natural selection? The solution to the paradox was first addressed by Anthony C. Allison in the 1950s and has since received considerable attention from other scholars, notably F. B. Livingstone. As a result of this attention, the sickle cell allele has emerged as the first and still best understood example of the role of infectious disease and human behavior in natural selection; it remains the model on which interpretation of other genetic disorders such as Tay-Sachs disease and cystic fibrosis is based.
All three are examples of “balanced polymorphisms” in which an allele deleterious in homozygotes is maintained in a population because in the heterozygote form it provides protection from an infectious disease. In the case of the sickle cell trait, the heterozygote HbS-HbA tends to resist malaria, itself one of the most significant debilitating and often fatal diseases affecting human beings throughout history. Malaria has been a major force in human evolution. The sickle cell trait is an example of how rapidly the spread of a disease can result in significant evolutionary change in the human species. Individuals possessing the allele are less likely to harbor the malarial parasite in significant numbers in comparison to homozygote normals. They live longer and are less affected by symptoms of malaria. Heterozygote women may be more fertile; men may also be more fertile because high fevers associated with malaria can reduce spermatogenesis. In malarial areas, both the homozygote HbA and the homozygote HbS are selected against. For every 100 heterozygote survivors in malarial areas, there are only about 88 HbA homozygote survivors and only 14 HbS homozygote survivors. The relative success of the heterozygote results in perpetuation of the HbS allele. (Tay-Sachs disease may be a similar response to tuberculosis, cystic fibrosis, cholera, typhoid, or other intestinal infection.)
The relationship between the sickle cell allele and malaria has been demonstrated sequentially in three ways. First, it has been shown that allowing for some movement of populations and malarial zones, the geographical concordance of HbS (and/or other forms of abnormal protective forms of hemoglobin, including HbC, HbE, HbO, variants of the Duffy blood group, various forms of thalassemia, and the enzyme G6PD, or glucose 6 phosphate dehydrogenase) with malaria is striking and too detailed to reflect mere chance. Figure 1 depicts the broad geographical correlation of the allele and the disease. The detailed correlation in specific locations such as various altitudes adds to the strength of the correlation. Allison (1954), for example, reports that there is no indigenous group in Africa with a high percentage of the S allele in which malaria is not present. It is, for example, rare in highlands and dry areas inhospitable to Anopheles mosquitoes. It is also less common where swidden agriculture is not the norm.
Second, the fitness effects of the HbS allele (as above) have been demonstrated repeatedly. Third, it has been shown that the structure of the sickled red blood cell is less able to support the growth of the protozoan malarial parasite, demonstrating the mechanisms by which heterozygotes are protected against malaria.
The history of the sickle cell allele is bound to that of the spread of malaria, which is in turn bound to the emergence of agricultural economies in the afflicted areas within the last 6,000 years, when falciparum malaria spread in an explosive manner. In West Africa it spread probably in association with the expansion of Bantu farmers into areas previously devoted to hunting and gathering in the last 2,000 to 3,000 years.
Forest clearance associated with farming created the mix of light and shade that in humid climates is highly favorable to Anopheles mosquitoes, which are the most efficient vectors of falciparum malaria. In addition, large populations and the sedentary communities that emerged with farming provided a larger pool of susceptible people, permitting the disease to become endemic. Farming also created layers of highly impenetrable lateritic soils, which in turn led to more standing water where mosquitoes could breed. It also tended to remove or displace other mammals as potential victims of mosquitoes, which then focused the attention of the mosquitoes on human beings.
MODERN-DAY ISSUES
Sickle cell anemia is also in some sense a dietary deficiency disease, at least in the United States. Its effects are mitigated to a significant degree by diets rich in cyanate and thiocyanate, which are typically found in tropical foods such as yams, manioc (cassava), sorghum, and some millets that are rarely eaten in the United States. Symptoms are often worse in the United States than in areas where these foods are more often consumed. The sickle cell trait has been found to be more common in areas of Africa where these foods are eaten, presumably because they reduce the severity of the symptoms, thus changing the balance of selective pressures. Yams, however, also reduce resistance to malaria, often resulting in patterns of yam consumption in Central Africa carefully balanced with seasonal malaria.
In the United States and other areas with the benefits of modern biomedicine, the symptoms of this disease can be alleviated by a therapeutic diet rich in cyanates and antioxidants. It has become possible to identify the presence of the gene by a simple blood test. Prenatal testing of fetuses for the presence of HbS and genetic counseling for heterozygote parents are available. Since 1984 it has been possible to fight HbS with bone marrow transplants from “normal” homozygotes. As of 1995 there has also been a therapy, hydroxyurea, that effectively treats symptoms.
Although often considered a “racial” concomitant of dark skin, sickle cell genetics actually provides one of many pieces of evidence demonstrating that biologically, “races” do not exist. Sickle cell hemoglobin is not limited to individuals of dark skin, and its correlation with dark skin is actually weak. Even in populations where it is endemic, such as in malarial regions of West Africa, no more than 10 to 30 percent of hemoglobin alleles are of the HbS form. The comparable figure in African Americans is no more than 5 percent. In other areas of Africa where malaria is less of a problem, the allele occurs in far lower frequencies or not at all. It does not occur among unrelated dark-skinned populations of Oceania or Australia. That is, the overwhelming majority of dark-skinned people, even those from or derived from West Africa, do not carry the allele. Conversely, the allele is known in malarial areas north of the Mediterranean, from southern Europe to India, among populations normally considered “white.” It is interesting to speculate that if Mediterranean populations from Spain, Portugal, Greece, Italy, or Turkey had been the main colonizers of the New World, and if they had obtained their slaves from some areas of North and South Africa or Australia, the sickle cell trait might be associated with light rather than dark skin.
SEE ALSO Diseases, Racial; Life Expectancy; Tay-Sachs and “Jewish” Diseases.
BIBLIOGRAPHY
Allison, Anthony C. 1954. “Protection Afforded by the Sickle Cell Trait against Malarial Infection.” British Medical Journal 1:290–294.
_____.2004. “Two Lessons from the Interface of Genetics and Medicine.” Genetics 166 (4): 1591–1599.
Livingstone, Frank B. 1958. “Anthropological Implications of Sickle Cell Gene Distribution in West Africa.” American Anthropologist 60 (3): 533–562.
Molnar, Stephen. 2005. Human Variation: Races, Types, and Ethnic Groups, 6th ed. Upper Saddle River, NJ: Pearson Prentice Hall.
Weiss, Kenneth M. 1993. Genetic Variation and Human Disease: Principles and Evolutionary Approaches. Cambridge, U.K.: Cambridge University Press.
Mark Nathan Cohen
